{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T07:00:15Z","timestamp":1774681215210,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Department of Cardiology at Danderyds Hospital"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ijcard.2019.03.005","type":"journal-article","created":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T17:07:32Z","timestamp":1551719252000},"page":"57-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Deactivation of implantable defibrillators at end of life \u2014 Can we do better?"],"prefix":"10.1016","volume":"291","author":[{"given":"Annika","family":"Kinch Westerdahl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jackline","family":"Magnsj\u00f6","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viveka","family":"Frykman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2019.03.005_bb0005","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/europace\/euu219","article-title":"Efficacy of primary preventive ICD therapy in an unselected population of patients with reduced left ventricular ejection fraction","volume":"17","author":"Sjoblom","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.ijcard.2019.03.005_bb0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2019.03.005_bb0015","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.02.032","volume":"51","author":"Epstein","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.03.005_bb0020","first-page":"1601","volume":"17","author":"Priori","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.ijcard.2019.03.005_bb0025","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.amjcard.2005.11.048","article-title":"Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic?","volume":"97","author":"Germano","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2019.03.005_bb0030","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.hrthm.2015.02.035","article-title":"The clinical course of patients with implantable cardioverter-defibrillators: extended experience on clinical outcome, device replacements, and device-related complications","volume":"12","author":"van der Heijden","year":"2015","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ijcard.2019.03.005_bb0035","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1161\/CIRCULATIONAHA.104.526673","article-title":"Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial","volume":"111","author":"Sweeney","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2019.03.005_bb0040","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.2013.4598","article-title":"Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial","volume":"309","author":"Gasparini","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2019.03.005_bb0045","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1540-8159.2000.tb00877.x","article-title":"Patients' attitudes toward implanted defibrillator shocks","volume":"23","author":"Ahmad","year":"2000","journal-title":"Pacing Clin. Electrophysiol."},{"key":"10.1016\/j.ijcard.2019.03.005_bb0050","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/pace.12276","article-title":"Anxiety disorders in patients with implantable cardioverter defibrillators: frequency, course, predictors, and patients' requests for treatment","volume":"37","author":"Lang","year":"2014","journal-title":"Pacing Clin. Electrophysiol."},{"key":"10.1016\/j.ijcard.2019.03.005_bb0055","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1161\/hc0502.103330","article-title":"Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks","volume":"105","author":"Schron","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2019.03.005_bb0060","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.hfc.2015.07.001","article-title":"End-of-life heart failure care in the United States","volume":"11","author":"Buggey","year":"2015","journal-title":"Heart Fail. Clin."},{"key":"10.1016\/j.ijcard.2019.03.005_bb0065","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.hrthm.2010.04.033","article-title":"HRS expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy","volume":"7","author":"Lampert","year":"2010","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ijcard.2019.03.005_bb0070","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/europace\/eun122","volume":"10","author":"Wilkoff","year":"2008","journal-title":"Europace"},{"key":"10.1016\/j.ijcard.2019.03.005_bb0075","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1093\/europace\/euq275","article-title":"EHRA expert consensus statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy","volume":"12","author":"Padeletti","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.ijcard.2019.03.005_bb0080","doi-asserted-by":"crossref","first-page":"835","DOI":"10.7326\/0003-4819-141-11-200412070-00006","article-title":"Management of implantable cardioverter defibrillators in end-of-life care","volume":"141","author":"Goldstein","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2019.03.005_bb0085","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/CIRCULATIONAHA.113.002648","article-title":"Implantable cardioverter-defibrillator therapy before death: high risk for painful shocks at end of life","volume":"129","author":"Kinch Westerdahl","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2019.03.005_bb0090","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/pace.12188","article-title":"End-of-life care in patients with implantable cardioverter defibrillators: a MADIT-II substudy","volume":"36","author":"Sherazi","year":"2013","journal-title":"Pacing Clin. Electrophysiol."},{"key":"10.1016\/j.ijcard.2019.03.005_bb0095","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ijcard.2015.01.012","article-title":"Defibrillator patients should not be denied a peaceful death","volume":"182","author":"Westerdahl","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2019.03.005_bb0100","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/europace\/euu233","article-title":"Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry","volume":"17","author":"Gadler","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.ijcard.2019.03.005_bb0105","series-title":"Swedish ICD and Pacemaker Register","article-title":"Annual statistical report 2014","author":"Register SIaP","year":"2014"},{"key":"10.1016\/j.ijcard.2019.03.005_bb0110","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"Lang","year":"2005","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.ijcard.2019.03.005_bb0115","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0735-1097(95)00482-3","article-title":"Classification of death in antiarrhythmia trials","volume":"27","author":"Epstein","year":"1996","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.03.005_bb0120","author":"Swedish ICD and Pacemaker Register"},{"key":"10.1016\/j.ijcard.2019.03.005_bb0125","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1093\/eurheartj\/ehm305","article-title":"Guidelines for cardiac pacing and cardiac resynchronization therapy: the Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association","volume":"28","author":"Vardas","year":"2007","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2019.03.005_bb0130","doi-asserted-by":"crossref","first-page":"e385","DOI":"10.1161\/CIRCULATIONAHA.106.178233","volume":"114","author":"Zipes","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2019.03.005_bb0135","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/europace\/euq282","article-title":"European utilization of the implantable defibrillator: has 10\u202fyears changed the \u2018enigma\u2019?","volume":"12","author":"John Camm","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.ijcard.2019.03.005_bb0140","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1540-8159.2011.03150.x","article-title":"The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009\u2013a World Society of Arrhythmia's project","volume":"34","author":"Mond","year":"2011","journal-title":"Pacing Clin. Electrophysiol."},{"key":"10.1016\/j.ijcard.2019.03.005_bb0145","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/europace\/euq316","article-title":"Management of patients receiving implantable cardiac defibrillator shocks: recommendations for acute and long-term patient management","volume":"12","author":"Braunschweig","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.ijcard.2019.03.005_bb0150","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.hrthm.2012.04.021","article-title":"The mode of death in implantable cardioverter-defibrillator and cardiac resynchronization therapy with defibrillator patients: results from routine clinical practice","volume":"9","author":"Thijssen","year":"2012","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ijcard.2019.03.005_bb0155","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0735-1097(02)01784-9","article-title":"Sudden death in patients with implantable cardioverter defibrillators: the importance of post-shock electromechanical dissociation","volume":"39","author":"Mitchell","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.03.005_bb0160","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1161\/CIRCHEARTFAILURE.110.957480","article-title":"A systematic assessment of causes of death after heart failure onset in the community: impact of age at death, time period, and left ventricular systolic dysfunction","volume":"4","author":"Lee","year":"2011","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2019.03.005_bb0165","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cardfail.2013.12.007","article-title":"Noncardiovascular death, especially infection, is a significant cause of death in elderly patients with acutely decompensated heart failure","volume":"20","author":"Ueda","year":"2014","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2019.03.005_bb0170","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/europace\/eut416","article-title":"Awareness of indications for device therapy among a broad range of physicians: a survey study","volume":"16","author":"Hubinette","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.ijcard.2019.03.005_bb0175","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/europace\/eup236","article-title":"A national survey of clinician's knowledge of and attitudes towards implantable cardioverter defibrillators","volume":"11","author":"McHale","year":"2009","journal-title":"Europace"},{"key":"10.1016\/j.ijcard.2019.03.005_bb0180","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.4065\/83.10.1139","article-title":"Physicians' preferences and attitudes about end-of-life care in patients with an implantable cardioverter-defibrillator","volume":"83","author":"Sherazi","year":"2008","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ijcard.2019.03.005_bb0185","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1540-8159.2012.03373.x","article-title":"Questionnaire survey of cardiologists' knowledge, attitudes, and guideline application of implantable cardioverter defibrillator therapy","volume":"35","author":"Sadarmin","year":"2012","journal-title":"Pacing Clin. Electrophysiol."},{"key":"10.1016\/j.ijcard.2019.03.005_bb0190","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1093\/europace\/eus432","article-title":"Deactivation of implantable cardioverter-defibrillators: results of patient surveys","volume":"15","author":"Herman","year":"2013","journal-title":"Europace"},{"key":"10.1016\/j.ijcard.2019.03.005_bb0195","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.ahj.2008.12.011","article-title":"Implantable cardioverter-defibrillator deactivation at the end of life: a physician survey","volume":"157","author":"Kelley","year":"2009","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2019.03.005_bb0200","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/europace\/euq272","article-title":"Deactivation of implanted cardioverter-defibrillators at the end of life: results of the EHRA survey","volume":"12","author":"Marinskis","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.ijcard.2019.03.005_bb0205","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1191\/0269216304pm907cr","article-title":"Dying and defibrillation: a shocking experience","volume":"18","author":"Nambisan","year":"2004","journal-title":"Palliat. Med."},{"key":"10.1016\/j.ijcard.2019.03.005_bb0210","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1161\/CIRCULATIONAHA.113.001555","article-title":"Managing with pacemakers and implantable cardioverter defibrillators","volume":"128","author":"Lampert","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2019.03.005_bb0215","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.hrtlng.2012.11.006","article-title":"Patients' experiences of the implantable cardioverter defibrillator (ICD); with a focus on battery replacement and end-of-life issues","volume":"42","author":"Fluur","year":"2013","journal-title":"Heart Lung"},{"issue":"Suppl. 1","key":"10.1016\/j.ijcard.2019.03.005_bb0220","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11606-007-0239-8","article-title":"\u201cThat's like an act of suicide\u201d patients' attitudes toward deactivation of implantable defibrillators","volume":"23","author":"Goldstein","year":"2008","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.ijcard.2019.03.005_bb0225","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1540-8159.2007.00771.x","article-title":"End-of-life decisions in ICD patients with malignant tumors","volume":"30","author":"Kobza","year":"2007","journal-title":"Pacing Clin. Electrophysiol."},{"key":"10.1016\/j.ijcard.2019.03.005_bb0230","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.amjcard.2013.01.296","article-title":"Patients' perspective on deactivation of the implantable cardioverter-defibrillator near the end of life","volume":"111","author":"Pedersen","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2019.03.005_bb0235","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1001\/jama.300.14.1665","article-title":"Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment","volume":"300","author":"Wright","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2019.03.005_bb0240","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/europace\/euw228","article-title":"Physicians' knowledge of implantable defibrillator treatment: are we good enough?","volume":"19","author":"Kinch Westerdahl","year":"2017","journal-title":"Europace"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318360388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318360388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:42:34Z","timestamp":1759092154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527318360388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":48,"alternative-id":["S0167527318360388"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2019.03.005","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deactivation of implantable defibrillators at end of life \u2014 Can we do better?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2019.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}